184 related articles for article (PubMed ID: 15249609)
21. Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migration.
Ganor Y; Besser M; Ben-Zakay N; Unger T; Levite M
J Immunol; 2003 Apr; 170(8):4362-72. PubMed ID: 12682273
[TBL] [Abstract][Full Text] [Related]
22. GluR3 autoantibodies destroy neural cells in a complement-dependent manner modulated by complement regulatory proteins.
Whitney KD; McNamara JO
J Neurosci; 2000 Oct; 20(19):7307-16. PubMed ID: 11007888
[TBL] [Abstract][Full Text] [Related]
23. Glutamate receptor GluR3 antibodies and death of cortical cells.
He XP; Patel M; Whitney KD; Janumpalli S; Tenner A; McNamara JO
Neuron; 1998 Jan; 20(1):153-63. PubMed ID: 9459451
[TBL] [Abstract][Full Text] [Related]
24. Febrile infection-related epilepsy syndrome without detectable autoantibodies and response to immunotherapy: a case series and discussion of epileptogenesis in FIRES.
van Baalen A; Häusler M; Plecko-Startinig B; Strautmanis J; Vlaho S; Gebhardt B; Rohr A; Abicht A; Kluger G; Stephani U; Probst C; Vincent A; Bien CG
Neuropediatrics; 2012 Aug; 43(4):209-16. PubMed ID: 22911482
[TBL] [Abstract][Full Text] [Related]
25. Glutamate receptor antibodies directed against AMPA receptors subunit 3 peptide B (GluR3B) can be produced in DBA/2J mice, lower seizure threshold and induce abnormal behavior.
Ganor Y; Goldberg-Stern H; Cohen R; Teichberg V; Levite M
Psychoneuroendocrinology; 2014 Apr; 42():106-17. PubMed ID: 24636507
[TBL] [Abstract][Full Text] [Related]
26. Antiglutamic acid decarboxylase antibodies in children with encephalitis and status epilepticus.
Lin JJ; Lin KL; Hsia SH; Wang HS; Chou IJ; Lin YT;
Pediatr Neurol; 2012 Oct; 47(4):252-8. PubMed ID: 22964438
[TBL] [Abstract][Full Text] [Related]
27. Neuronal nicotinic acetylcholine receptor antibodies in autoimmune central nervous system disorders.
Pechlivanidou M; Vakrakou AG; Karagiorgou K; Tüzün E; Karachaliou E; Chroni E; Afrantou T; Grigoriadis N; Argyropoulou C; Paschalidis N; Şanlı E; Tsantila A; Dandoulaki M; Ninou EI; Zisimopoulou P; Mantegazza R; Andreetta F; Dudeck L; Steiner J; Lindstrom JM; Tzanetakos D; Voumvourakis K; Giannopoulos S; Tsivgoulis G; Tzartos SJ; Tzartos J
Front Immunol; 2024; 15():1388998. PubMed ID: 38863705
[TBL] [Abstract][Full Text] [Related]
28. No effect of immunomodulatory therapy in focal epilepsy with positive glutamate receptor type 3--antibodies.
Feichtinger M; Wiendl H; Körner E; Holl A; Gruber L; Fazekas F; Schröttner O; Eder H; Ott E
Seizure; 2006 Jul; 15(5):350-4. PubMed ID: 16621617
[TBL] [Abstract][Full Text] [Related]
29. Glutamate receptor antibodies activate a subset of receptors and reveal an agonist binding site.
Twyman RE; Gahring LC; Spiess J; Rogers SW
Neuron; 1995 Apr; 14(4):755-62. PubMed ID: 7718238
[TBL] [Abstract][Full Text] [Related]
30. Autoimmune Epilepsy - Novel Multidisciplinary Analysis, Discoveries and Insights.
Levite M; Goldberg H
Front Immunol; 2021; 12():762743. PubMed ID: 35095841
[TBL] [Abstract][Full Text] [Related]
31. [Rasmussen encephalitis and non-herpetic acute limbic encephalitis].
Takahashi Y; Kubota Y; Yamasaki E; Matsuda K
Rinsho Shinkeigaku; 2008 Mar; 48(3):163-72. PubMed ID: 18409535
[TBL] [Abstract][Full Text] [Related]
32. Glutamate receptor subunit 3 (GluR3) immunoreactivity delineates a subpopulation of parvalbumin-containing interneurons in the rat hippocampus.
Moga DE; Janssen WG; Vissavajjhala P; Czelusniak SM; Moran TM; Hof PR; Morrison JH
J Comp Neurol; 2003 Jul; 462(1):15-28. PubMed ID: 12761821
[TBL] [Abstract][Full Text] [Related]
33. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.
Dalmau J; Gleichman AJ; Hughes EG; Rossi JE; Peng X; Lai M; Dessain SK; Rosenfeld MR; Balice-Gordon R; Lynch DR
Lancet Neurol; 2008 Dec; 7(12):1091-8. PubMed ID: 18851928
[TBL] [Abstract][Full Text] [Related]
34. Antibodies to AMPA receptors in Rasmussen's encephalitis.
Nibber A; Clover L; Pettingill P; Waters P; Elger CE; Bien CG; Vincent A; Lang B
Eur J Paediatr Neurol; 2016 Mar; 20(2):222-227. PubMed ID: 26785913
[TBL] [Abstract][Full Text] [Related]
35. Immune-mediated epilepsy with GAD65 antibodies.
Li X; Guo Q; Zheng Z; Wang X; Liu S
J Neuroimmunol; 2020 Apr; 341():577189. PubMed ID: 32087461
[TBL] [Abstract][Full Text] [Related]
36. Identification of amino acids in the glutamate receptor, GluR3, important for antibody-binding and receptor-specific activation.
Carlson NG; Gahring LC; Twyman RE; Rogers SW
J Biol Chem; 1997 Apr; 272(17):11295-301. PubMed ID: 9111034
[TBL] [Abstract][Full Text] [Related]
37. Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis.
Steiner J; Walter M; Glanz W; Sarnyai Z; Bernstein HG; Vielhaber S; Kästner A; Skalej M; Jordan W; Schiltz K; Klingbeil C; Wandinger KP; Bogerts B; Stoecker W
JAMA Psychiatry; 2013 Mar; 70(3):271-8. PubMed ID: 23344076
[TBL] [Abstract][Full Text] [Related]
38. An unusual case of coma related to glutamate receptor 3 (GluR3) auto-antibodies after a traumatic spinal cord injury: Clinical and pathological aspects.
Caputo F; Barranco R; Ricci P; Gratteri S; Castelletti L; Ravetti GL; Ventura F
Med Leg J; 2021 Jun; 89(2):133-136. PubMed ID: 33331219
[TBL] [Abstract][Full Text] [Related]
39. Neuronal antibodies in pediatric epilepsy: Clinical features and long-term outcomes of a historical cohort not treated with immunotherapy.
Wright S; Geerts AT; Jol-van der Zijde CM; Jacobson L; Lang B; Waters P; van Tol MJ; Stroink H; Neuteboom RF; Brouwer OF; Vincent A
Epilepsia; 2016 May; 57(5):823-31. PubMed ID: 26996997
[TBL] [Abstract][Full Text] [Related]
40. Dominant negative mutant of ionotropic glutamate receptor subunit GluR3: implications for the role of a cysteine residue for its channel activity and pharmacological properties.
Watase K; Sekiguchi M; Matsui TA; Tagawa Y; Wada K
Biochem J; 1997 Mar; 322 ( Pt 2)(Pt 2):385-91. PubMed ID: 9065754
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
